Abstract

Ninety-six patients with polymyalgia rheumatica were identified in Olmsted County, Minnesota, during the 10-year period 1970 to 1979. Giant cell arteritis was found in 15 of the 96 patients. The average annual incidence of polymyalgia rheumatica in the population increased from 19.8 per 100 000 in persons 50 to 59 years of age, to a maximum of 112.2 per 100 000 in persons 70 to 79 years of age. Eighty-three of the 96 patients (86%) had recovered by the end of the study. Median duration of the disease was 11 months (range, 2 to 54 months). Polymyalgia rheumatica had no effect on survival. Both corticosteroids and nonsteroidal anti-inflammatory drugs were used in treatment. Response was more rapid in patients given corticosteroids, but nonsteroidal drugs were used successfully, especially in milder cases. Relapses and adverse reactions to treatment were more frequent in patients given corticosteroids. The findings show that polymyalgia rheumatica is a relatively common disease in middle-aged and older persons and generally runs a self-limited course.

References

  • 1. BRUCE W. Senile rheumatic gout. Br Med J. 1888;2:811-3. CrossrefMedlineGoogle Scholar
  • 2. BARBER H. Myalgic syndrome with constitutional effects: polymyalgia rheumatica. Ann Rheum Dis. 1957;16:230-7. CrossrefMedlineGoogle Scholar
  • 3. LEVEY GCAREY J, and CALABRO J. Polymyalgia rheumatica: a separate rheumatic entity? Arthritis Rheum. 1963;6:75-7. CrossrefMedlineGoogle Scholar
  • 4. KURLAND LELVEBACK L, and NOBREGA F. Population studies in Rochester and Olmsted County, Minnesota, 1900-1968. In: KESSLER II, LEVIN ML, eds. The Community as an Epidemiologic Laboratory: A Casebook of Community Studies. Baltimore: Johns Hopkins Press; 1970:47-70. Google Scholar
  • 5. KURLAND LELVEBACK L, and NOBREGA F. Mayo Clinic records linkage system in the Rochester-Olmsted Epidemiology Program Project. In: Proceedings of the Sixth International Scientific Meeting on the Uses of Epidemiology in Planning Health Services. Belgrade: International Epidemiological Association; 1973:164-76. Google Scholar
  • 6. KAPLAN E and MEIER P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81. CrossrefGoogle Scholar
  • 7. LINOS AWORTHINGTON JO'FALLON W, and KURLAND L. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol. 1980;111:87-98. CrossrefMedlineGoogle Scholar
  • 8. HUSTON KHUNDER GLIE JKENNEDY R, and ELVEBACK L. Temporal arteritis: a 25-year-epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88:162-7. LinkGoogle Scholar
  • 9. ROPES MBENNETT GCOBB SJACOX R, and JESSAR R. 1958 revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum. 1959;2:16-20. CrossrefMedlineGoogle Scholar
  • 10. POLLEY H and HUNDER G. Rheumatologic Interviewing and Physical Examination of the Joints. Philadelphia: W. B. Saunders Co.; 1978. Google Scholar
  • 11. DIXON ABEARDWELL CKAY AWANKA J, and WONG Y. Polymyalgia rheumatica and temporal arteritis. Ann Rheum Dis. 1966;25:203-8. CrossrefMedlineGoogle Scholar
  • 12. HAMRIN B. Polymyalgia arteritica. Acta Med Scand. 1972;533(suppl):1-131. Google Scholar
  • 13. BENGTSSON B and MALMVALL B. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica: incidences of different clinical presentations and eye complications. Arthritis Rheum. 1981;24:899-904. CrossrefMedlineGoogle Scholar
  • 14. CALAMIA K and HUNDER G. Clinical manifestations of giant cell (temporal) arteritis. Clin Rheum Dis. 1980;6:389-403. CrossrefGoogle Scholar
  • 15. WILSKE K and HEALEY L. Polymyalgia rheumatica: a manifestation of systemic giant-cell arteritis. Ann Intern Med. 1967;66:77-86. LinkGoogle Scholar
  • 16. FAUCHALD PRYGVOLD O, and ØYSTESE B. Temporal arteritis and polymyalgia rheumatica: clinical and biopsy findings. Ann Intern Med. 1972;77:845-52. LinkGoogle Scholar
  • 17. MYLES A. Polymyalgia rheumatica and giant cell arteritis: a seven-year survey. Rheumatol Rehabil. 1975;14:231-5. CrossrefMedlineGoogle Scholar
  • 18. COOMES EELLIS R, and KAY A. A prospective study of 102 patients with the polymyalgia rheumatica syndrome. Rheumatol Rehabil. 1976;15:270-6. CrossrefMedlineGoogle Scholar
  • 19. SPIERA H and DAVISON S. Long-term follow-up of polymyalgia rheumatica. Mt Sinai J Med (NY). 1978;45:225-9. MedlineGoogle Scholar
  • 20. MOWAT A and HAZLEMAN B. Polymyalgia rheumatica: a clinical study with particular reference to arterial disease. J Rheumatol. 1974; 1:190-202. MedlineGoogle Scholar
  • 21. BRUK M. Articular and vascular manifestations of polymyalgia rheumatica. Ann Rheum Dis. 1967;26:103-16. CrossrefMedlineGoogle Scholar
  • 22. GORDON I. Polymyalgia rheumatica: a clinical study of 21 cases. Q J Med. 1960;29:473-88. MedlineGoogle Scholar
  • 23. VON KNORRING J. Treatment and prognosis in polymyalgia rheumatica and temporal arteritis: a ten-year survey of 53 patients. Acta Med Scand. 1979;205:429-35. CrossrefMedlineGoogle Scholar
  • 24. KATTWINKEL N and FERNANDEZ-HERLIHY L. Polymyalgia rheumatica and temporal arteritis. Lahey Clin Found Bull. 1970;19:41-8. MedlineGoogle Scholar
  • 25. SØRENSEN P and LORENZEN I. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica: a retrospective study of 63 patients. Acta Med Scand. 1977;201:207-13. CrossrefMedlineGoogle Scholar
  • 26. GERBER N and VERNON-ROBERTS B. Polymyalgia Rheumatica: klinisch-histologische Studie an 46 Fällen. Z Rheumatol. 1977;36:275-84. MedlineGoogle Scholar
  • 27. LIANG GSIMKIN PHUNDER GWILSKE K, and HEALEY L. Familial aggregation of polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 1974;17:19-24. CrossrefMedlineGoogle Scholar
  • 28. DAILEY M and MCCARTY D. Polymyalgia rheumatica begins at 40. Arch Intern Med. 1979;139:743-4. CrossrefMedlineGoogle Scholar
  • 29. MILLER L and STEVENS M. Skeletal manifestations of polymyalgia rheumatica. JAMA. 1978;240:27-9. CrossrefMedlineGoogle Scholar
  • 30. HUNDER GDISNEY T, and WARD L. Polymyalgia rheumatica. Mayo Clin Proc. 1969;44:849-75. MedlineGoogle Scholar
  • 31. HUNDER G and ALLEN G. The relationship between polymyalgia rheumatica and temporal arteritis. Geriatrics. 1973;28 (June):134-42. Google Scholar
  • 32. BAGRATUNI L. Prognosis in the anarthritic rheumatoid syndrome. Br Med J. 1963;1:513-8. CrossrefMedlineGoogle Scholar
  • 33. HENDERSON DTRIBE C, and DIXON A. Synovitis in polymyalgia rheumatica. Rheumatol Rehabil. 1975;14:244-50 CrossrefMedlineGoogle Scholar
  • 34. HUSKISSON EDIEPPE P, and BALME H. Complicated polymyalgia. Br Med J. 1977;2:1459. CrossrefMedlineGoogle Scholar
  • 35. O'DUFFY JHUNDER G, and WAHNER H. A follow-up study of polymyalgia rheumatica: evidence of chronic axial synovitis. J Rheumatol. 1980;7:685-93. MedlineGoogle Scholar
  • 36. CECIL R and KAMMERER W. Rheumatoid arthritis in the aged. Am J Med. 1951;10:439-45. CrossrefMedlineGoogle Scholar
  • 37. CAMMARATA RRODNAN G, and FENNELL R. Serum anti-γ-globulin and antinuclear factors in the aged. JAMA. 1967;199:455-8. CrossrefMedlineGoogle Scholar
  • 38. HOOPER BWHITTINGHAM SMATHEWS JMACKAY I, and CURNOW D. Autoimmunity in a rural community. Clin Exp Immunol. 1972;12:79-87. MedlineGoogle Scholar
  • 39. ESSELINCKX WDOHERTY S, and DIXON A. Polymyalgia rheumatica: abrupt and gradual withdrawal of prednisolone treatment, clinical and laboratory observations. Ann Rheum Dis. 1977;36:219-24. CrossrefMedlineGoogle Scholar
  • 40. JONES J and HAZLEMAN B. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981;40:1-5. CrossrefMedlineGoogle Scholar
  • 41. O'BRIEN P and SHAMPO M. Descriptive statistics. Mayo Clin Proc. 1981;56:47-9. MedlineGoogle Scholar

This content is PDF only. To continue reading please click on the PDF icon.